Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques

Thrombosis Journal

Volumn 9, Issue , 2011, Pages

  V Baroncini, Liz A ^a   Nakao, Lia S ^b   Ramos, Simone G ^c   Filho, Antonio P ^c   Murta Jr, Luiz O ^c   Ingberman, Max ^b   Tefé Silva, Cristiane ^c   Précoma, Dalton B ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLOOXYGENASE 2; GELATINASE B; LIPID; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AGED; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MUSCLE CELL; PROTEIN EXPRESSION;

EID: 79953240805     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-9-6     Document Type: Article

References (28)

1. Baroncini LAV, Pazin Filho A, Ramos SG, Martins AR, Murta LO. Histological composition and progression of carotid plaque. Thrombosis Journal 2007, 5:4. 10.1186/1477-9560-5-4, 1808443, 17324272.
2. Tziakas DN, Lazarides MK, Tentes IK, Georgiadis GS, Eleftheriadou E, Chalikias GK, Kortsaris A, Hatseras DI. Gelatinases [Matrix Metalloproteinase-2 (MMP-2) and MMP-9] induce carotid plaque instability but their systemic levels are not predictive of local events. Ann Vasc Surg 2005, 19:529-533. 10.1007/s10016-005-5018-6, 15981119.
3. Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis 2010,
4. Peeters W, Hellings WE, Kleijn DPV, Vries JPPM, Moll FL, Vink A, Pasterkamp G. Carotid atherosclerotic plaques stabilize after Stroke. Insights into the natureal process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009, 29:128-133. 10.1161/ATVBAHA.108.173658, 18931283.
5. Orbe J, Fernandez L, Rodriguez JA, Rábago G, Belzunce M, Monastério A, Roncal C, Páramo JA. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 2003, 170:269-276. 10.1016/S0021-9150(03)00251-X, 14612207.
6. Fiotti N, Xiong W, Giansante C. MMP-2 genetic variant and plaque features of instability. Atherosclerosis 2010, 210:43-44. 10.1016/j.atherosclerosis.2010.02.019, 20236643.
7. Hector EE, Robins SP, Mercer DK, Brittenden J, Wainwright C. Quantitative measurement of mature collagen cross-links in human carotid artery plaques. Atherosclerosis 2010, 211:471-474. 10.1016/j.atherosclerosis.2010.03.028, 20417515.
8. Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A. Blockade of the Angiotensina II Type 1 receptor stabilizes atherosclerotic plaques in human inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 2004, 109:1482-1488. 10.1161/01.CIR.0000121735.52471.AC, 15037537.
9. Cipollone F, Fazia M, Iezzi A, Zucchelli M, Pini B, De Cesare D, Ucchino S, Spigonardo F, Bajocchi G, Bei R, Muraro R, Artese L, Piattelli A, Chiarelli F, Cuccurullo F, Mezzetti A. Suppression of the functionally coupled cyclooxygenase-2/PGE synthase as a basis of simvastatim-dependent plaque stabilization in humans. Circulation 2003, 107:1479-1485. 10.1161/01.CIR.0000056530.03783.81, 12654603.
10. Van Oostrom O, Velema E, Schoneveld AH, Vries JPPM, Bruim P, Seldenrijk CA, Kleijn DPV, Busser E, Moll FL, Verheijen JH, Virmani R, Pasterkamp G. Age-related changes in plaque composition. A study in patients suffering from carotid artery stenosis. Cardiovascular Pathology 2005, 14:126-134. 10.1016/j.carpath.2005.03.002, 15914297.
11. Hellings WE, Moll FL, Vries JPPM, Bruin P, Kleijn DPV, Pasterkamp G. Histological characterization of restenotic carotid plaques in relation to recurrence interval and clinical presentation. A cohort study. Stroke 2008, 39:1029-1032. 10.1161/STROKEAHA.107.496703, 18258835.
12. Kong YZ, Yu X, Tang JJ, Ouyang X, Huang XR, Rowson GF, Bacher M, Scher LA, Bucala R, Lan HY. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 2005, 178:207-215. 10.1016/j.atherosclerosis.2004.08.030, 15585220.
13. Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability. Circulation 2001, 104:921-927. 10.1161/hc3401.093152, 11514380.
14. Turu MM, Krupinski J, Catena E, Rosell A, Montaner J, Rubio F, Alvarez-Sabin J, Cairols M, Badimon L. Intraplaque MMP-8 level are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2005, 187:161-169. 10.1016/j.atherosclerosis.2005.08.039, 16259988.
15. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1512-1531.
16. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002, 106:1368-1373. 10.1161/01.CIR.0000028591.44554.F9, 12221054.
17. Higashikata T, Yamagishi M, Higashi T, Nagata I, Iihara K, Miyamoto S, Ishibashi-Ueda H, Nagaya N, Iwase T, Tomoike H, Sakamoto A. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: Results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis 2006, 185:165-172. 10.1016/j.atherosclerosis.2005.05.039, 16039658.
18. Fiotti N, Moretti ME, Bussani R, Altamura N, Zamolo F, Gerloni R, Ukovich L, Ober E, Silvestri F, Grassi G, Adovasio R, Giansante C. Features of vulnerable plaques and clinical outcome of UA/NSTEMI: relationship with matrix metalloproteinase functional polymorphisms. Atherosclerosis 2011, 215:153-159. 10.1016/j.atherosclerosis.2010.12.010, 21232745.
19. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rhode LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix-metalloproteinase-9 attenuates legt ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000, 106:55-62. 10.1172/JCI8768, 517910, 10880048.
20. Redgrave JNE, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing os ischemic symptoms. The Oxford Plaque Study. Circulation 2006, 113:2320-2328.
21. Kunte H, Amberger N, Busch MA, Ruckert RI, Meiners S, Harms L. Markes of instability in high-risk carotid plaques are reduced by statins. J Vasc Surg 2008, 47:513-522. 10.1016/j.jvs.2007.11.045, 18295103.
22. Kaneider NC, Mosheimer B, Gunther A, Feistritzer C, Wiedermann CJ. Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thrombosis Journal 2010, 8:2. 10.1186/1477-9560-8-2, 2837620, 20181055.
23. Peeters W, Hellings WE, Kleijn DPV, Vries JPPM, Moll FL, Pasterkamp G. Carotid atherosclerotic plaques stabilize after stroke. Insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009, 29:128-133. 10.1161/ATVBAHA.108.173658, 18931283.
24. Kunte H, Kunte G, Busch MA, Weichert W, Ruckert RI, Harms L. Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis. Atherosclerosis 2010, 211:456-460. 10.1016/j.atherosclerosis.2010.03.005, 20427044.
25. Johnson C, Galis ZS. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2004, 24:54-60. 10.1161/01.ATV.0000100402.69997.C3, 14551157.
26. Turu MM, Krupinski J, Catena E, Rosell A, Montaner J, Rubio F, Alvarez-Sabin J, Cairols M, Badimon L. Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006, 187:161-169. 10.1016/j.atherosclerosis.2005.08.039, 16259988.
27. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad and the ugly. Circ Res 2002, 90:251-262.
28. Fiotti N, Xiong W, Giansante C. MMP-2 genetic variant and plaque features of instability. Atherosclerosis 2010, 210:43-44. 10.1016/j.atherosclerosis.2010.02.019, 20236643.